Project to support adoption of the io® rapid diagnostic platform into UK sexual health clinics Bath, UK, 14 August, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company,…
Financing global launch and menu development of Atlas Genetics’ io® molecular testing system Bath, UK, 23 January, 2017. Atlas Genetics Ltd., the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces…
CE-marked CT test gives results in 30 minutes Bath, UK, 02 June 2016. Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the STI Point-Of-Care (POC) molecular diagnostics company, today notes…
